Misfolded CuZnSOD and amyotrophic lateral sclerosis

被引:484
作者
Valentine, JS [1 ]
Hart, PJ
机构
[1] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90025 USA
[2] Univ Texas, Hlth Sci Ctr, X Ray Crystallog Core Lab, San Antonio, TX 78229 USA
[3] Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78229 USA
关键词
D O I
10.1073/pnas.0730423100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Amyotrophic lateral sclerosis (ALS) is a progressive degenerative disease of motor neurons. The inherited form of the disease, familial ALS, represents 5-10% of the total cases, and the best documented of these are due to lesions in SOD1, the gene encoding copper-zinc superoxide dismutase (CuZnSOD). The mechanism by which mutations in SOD1 cause familial ALS is currently unknown. Two hypotheses have dominated recent discussion of the toxicity of ALS mutant CuZnSOD proteins: the oligomerization hypothesis and the oxidative damage hypothesis. The oligomerization hypothesis maintains that mutant CuZnSOD proteins are, or become, misfolded and consequently oligomerize into increasingly high-molecular-weight species that ultimately lead to the death of motor neurons. The oxidative damage hypothesis maintains that ALS mutant CuZnSOD proteins catalyze oxidative reactions that damage substrates critical for viability of the affected cells. This perspective reviews some of the properties of both wild-type and mutant CuZnSOD proteins, suggests how these properties may be relevant to these two hypotheses, and proposes that these two hypotheses are not necessarily mutually exclusive.
引用
收藏
页码:3617 / 3622
页数:6
相关论文
共 78 条
  • [1] Analysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant defenses, and nitric oxide synthetic pathways
    Allen, S
    Heath, PR
    Kirby, J
    Wharton, SB
    Cookson, MR
    Menzies, FM
    Banks, RE
    Shaw, PJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (08) : 6371 - 6383
  • [2] Andrus PK, 1998, J NEUROCHEM, V71, P2041
  • [3] Azzouz M, 2000, J NEUROBIOL, V42, P49, DOI 10.1002/(SICI)1097-4695(200001)42:1<49::AID-NEU5>3.0.CO
  • [4] 2-7
  • [5] Superoxide dismutase and the death of motoneurons in ALS
    Beckman, JS
    Estévez, AG
    Crow, JR
    [J]. TRENDS IN NEUROSCIENCES, 2001, 24 (11) : S15 - S20
  • [6] ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions
    Bruijn, LI
    Becher, MW
    Lee, MK
    Anderson, KL
    Jenkins, NA
    Copeland, NG
    Sisodia, SS
    Rothstein, JD
    Borchelt, DR
    Price, DL
    Cleveland, DW
    [J]. NEURON, 1997, 18 (02) : 327 - 338
  • [7] Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1
    Bruijn, LI
    Houseweart, MK
    Kato, S
    Anderson, KL
    Anderson, SD
    Ohama, E
    Reaume, AG
    Scott, RW
    Cleveland, DW
    [J]. SCIENCE, 1998, 281 (5384) : 1851 - 1854
  • [8] CABELLI DE, 1989, J BIOL CHEM, V264, P9967
  • [9] Insights into Lou Gehrig's disease from the structure and instability of the A4V mutant of human Cu,Zn superoxide dismutase
    Cardoso, RMF
    Thayer, MM
    DiDonato, M
    Lo, TP
    Bruns, CK
    Getzoff, ED
    Tainer, JA
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2002, 324 (02) : 247 - 256
  • [10] From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS
    Cleveland, DW
    Rothstein, JD
    [J]. NATURE REVIEWS NEUROSCIENCE, 2001, 2 (11) : 806 - 819